Background: Although psoriasis occurs worldwide, the prevalence varies considerably between different peoples and regions. In China, a questionnaire-based study was carried out in 1987 and the prevalence of psoriasis was found to be 0.12%. Since then, no large-scale, populationbased study has been reported. Objectives: To obtain the accurate figures for the prevalence of psoriasis in China. Methods: A population-based survey was conducted in 6 cities. The cluster sampling method was used to select communities in each city. The subjects were required to fill out self-reporting questionnaires during a face-to-face interview and also received physical examination by dermatologists. Results: 19,974 subjects were visited and 17,345 completed the questionnaires and received dermatological examination. 102 subjects (0.59%) were found to have psoriasis. After standardization, the prevalence of psoriasis was 0.47%. The prevalence of psoriasis in males and females was 0.54% and 0.44% respectively. 97.06% of the patients had psoriasis vulgaris. 28.43% of the patients reported a family history of psoriasis. 59.80% of patients experienced a negative influence on the quality of life. Conclusions: This population-based and dermatologist-confirmed study showed that the prevalence of psoriasis in China is 0.47%, which is higher than that reported in 1987.
P soriasis is a chronic inflammatory disease characterized by hyperproliferation of epidermal keratinocytes and inflammatory infiltration. Although rarely life-threatening, psoriasis is associated with a high degree of morbidity and a poor quality of life. Patients are embarrassed by their disease, and generally have lower levels of employment rate and income. Psoriasis occurs worldwide. However, the prevalence varies considerably between peoples and countries [1] , ranging from 0-11.8% [2] . It is more common in cold regions compared to tropical regions. The prevalence is highest among Northern Europeans and is almost entirely absent in aboriginal populations of South America [1] . A population-based study on the prevalence of psoriasis in a community was conducted by Gunnar Lomholt in the Faroe Islands -an island group situated between the Norwegian Sea and the North Atlantic Ocean [3] . He examined 10,984 inhabitants in these relatively isolated islands and observed a prevalence of 2.8% [3] . An even higher prevalence of 4.8% has been reported in a population-based study from Norway. However, the self-reporting of psoriasis was not validated and could thus be an overestimation [4] . In another health interview survey of a sample of 10,576 Norwegians, the overall prevalence obtained was 1.4% [5] . In Denmark, the prevalence was 2.9% [6] . In the United Kingdom, the reported prevalence ranged from 1.5%-2.8% [7, 8] . Using the General Practice Research Database, which contains electronic medical record information on more than 8 million patients from 1987 to 2002, Gelfand et al. identified 114,521 patients with psoriasis out of a total population of 7,533,475 people, yielding a prevalence of 1.5% [8] . The prevalence in Spain, based on self-reporting of a random sample representative of the general population, was estimated to be 1.43%, with a higher prevalence in the central dry regions of the country [9] . In North America, population-based surveys are available from the United States. In 1996, a prevalence of 2.6% was reported by Koo [10] . The prevalence among AfricanAmericans has been reported to be lower compared to Caucasians [11] .
Estimates from a few regions of Asia have shown that psoriasis is less prevalent in China and Japan than European countries [4] . A recent study from Taiwan reported a mean one-year prevalence of psoriasis of 0.23% for men and 0.16% for women, respectively, in a national representative cohort of 1,000,0000 individuals from the National Health Insurance database followed up for the years 2000-2006 [12] . On the Chinese mainland, a large-scale epidemiological survey was carried out in 1987 and the study was questionnaire-based, without physiological examination by dermatologists. It revealed that the prevalence of psoriasis was 0.12% [13] . Since then, although there have been some epidemiological studies in single cities or regions, no multi-centre, population-based study has been carried out in China. The aim of this study was to obtain the prevalence of psoriasis in China through a multi-center and populationbased study.
Materials and methods
A community-based study was carried out in 6 different cities, Taiyuan in Shanxi province, Langfang in Hebei province, Hailar in the Inner Mongolia region, Zibo in Shandong province, Jiaozuo in Henan province, and Xichang in Sichuan province. In each city, three to five communities were selected for face-to-face investigations. The cluster sampling method was used to select communities. The target population included all the residents in selected communities. They were asked to complete questionnaires and undergo dermatological examination. The study was carried out by investigators including dermatologists from Peking University People's Hospital and dermatologists from local hospitals. All the investigators were thoroughly trained to properly carry out the procedures of the investigation, and were required to pass an examination for qualification. The age-and gender-adjusted prevalence of psoriasis (overall, in men and in women) were calculated based on the Chinese Population Composition in 2003. The Chi-square test was used for statistical analysis of comparison between groups.
Results
A total of 19,974 subjects were interviewed and 17,345 completed the questionnaires, (7,858 men and 9,487 women). The age of the study population ranged from 2 months to 99 years old (mean age 41.84 ± 21.59 years). 102 individuals (51 men and 51 women) were found to have psoriasis. The overall prevalence of psoriasis was 0.59%. After standardization, the prevalence was 0.47%. Table 1 shows the prevalence of psoriasis in men and women of different ages. The prevalence of psoriasis in men was 0.65% (0.54% after standardization). In women, the prevalence was 0.54% (0.44%after standardization). In both men and women, the prevalence increased with ages under 50 years old. Table 2 shows the prevalence of psoriasis in 6 cities. The highest prevalence was seen in Taiyuan (0.78%), followed by Langfang (0.70%), Jiaozuo (0.66%), Zibo (0.53%), Xichang (0.51%) and Hailar (0.31%). The differences between the prevalence of psoriasis for both men and women between these cities were not significant (P>0.05). Among 102 patients, 98 provided the age of onset. The onset age ranged from 4-78 years old (mean 36.23 ± 20.26 years). The peak of onset age was found to be in the 20-29 year group for both men and women (figure 1). 67.65% of the patients had the disease before 40 years old. The most common type of psoriasis was psoriasis vulgaris (97.06%). Psoriasis pustulosa was found in 1 patient (0.98%) and psoriasis arthropathica was found in 2 patients (1.96%). No psoriasis erythroderma was found. A positive family history for psoriasis was found in 28.43% of patients, which was much higher than that in total population (2.23%, P<0.01). The positive family history in men was 31.37% and 25.49% in women. Although psoriasis was found to occur at all ages, over 85% patients had the disease from 10 to 59 years old. About 30% patients experienced first onset at the age between 20 and 29 years old. 67.65% of the patients experienced the first onset before 40 years old. The onset age of psoriasis was similar between men and women.
58.82% of male patients and 60.78% of female patients with psoriasis experienced a negative impact on quality of life through their psoriasis. Although most patients (92.16%) had received treatment, there was still a small number of patients (7.84%) who had never received treatment for various reasons.
Discussion
Psoriasis is a chronic inflammatory skin disease. The disease appears to be more common in Caucasians, especially in Northern Europe and North-America, and less common in people with yellow and brown skin colors [14] . Some studies have been carried out to obtain the epidemiological features of psoriasis in different populations.
The results of these studies showed that the prevalence of psoriasis varied considerably, ranging from 0-11.8% (table 3) . Geographical location and ethnicity might be related to the prevalence of psoriasis. In addition, some other factors may contribute to such variables, such as the study population (population-based or hospital-based), age (all subjects, adults, children), the type of the prevalence estimate (point, period, lifetime), and most particularly the ascertainment methods (clinical examination, questionnaires, patient reports). Some studies were conducted by telephone calls or questionnaires without clinical examination of the subjects. These data might not reflect the real condition of the subjects. And in some surveys, the sample size was not sufficient to investigate the prevalence of psoriasis stratified by age and gender. In our study, we selected 6 cities located in 6 provinces of China. The sample size is relatively large. And to ensure the quality of the study, all subjects were examined by dermatologists. In this study, the prevalence of psoriasis in China is 0.47%, and men and women are equally affected. The results of this study and two other studies, one from the UK and one from China, are compared in figure 2 . In this study, the prevalence was much lower than that in UK [8] throughout Both Chinese studies showed that the prevalence of psoriasis in China was lower than that in UK. Comparing to another Chinese study performed in 1987, this study showed a similar prevalence of psoriasis in people under 40 years while it showed a higher prevalence in people over 40 years.
all ages. Comparing with the study from China in 1987 [13] , the prevalence of psoriasis in our study was similar in people under 40 years old while it was higher in people over 40 years. In our study, the prevalence increased with age in people under 50, after that, the prevalence declined a little. In the UK study and the study in China in 1987, the prevalence declined after 60 years of age. The onset of psoriasis can be at any age. Determination of the age of the onset of psoriasis is difficult because it is usually based on patients' recollection of the onset of the lesions, or is based on physicians' diagnosis on the initial visit. The onset may have occurred years prior to the patient's initial visit [14] . Nevertheless, the age of onset is still a very important part of epidemiological information. A bimodal age of onset had been reported in several large studies. The first peak was seen in people aged 15-20 years and the second peak occurred in the 55-60 year age range [15, 16] . Henseler and Christophers [17] examined a series of 2,147 patients and reported two clinical presentations of psoriasis, Type I and Type II, distinguished by a bimodal age at onset. Type I begins at or before 40 years; Type II begins after the age of 40 years. Type I disease accounts for more than 75% of patients. In our study, 67.65% of patients experienced their first outbreak of psoriasis before 40 years old. In another study, 75% of patients had psoriasis before 34 years old [13] . A few studies done on twins and families suggested a genetic predisposition of psoriasis. The study of Lomholt [3] in the Faroe Islands, involving the examination of 10,984 inhabitants, reported 90% incidence among firstand second-degree relatives. In other questionnaire-based studies or direct history-taking of patients in clinical practice, about 30-50% of patients indicated that they were aware of one or more affected first-or second-degree relatives. A study in China reported that among 1,043 patients with psoriasis, 326 (31.26%) had a positive family history [18] . In our study, 28.43% of patients had a positive family history, which was significantly higher than the natural population (2.23%).
Chandran et al reported that psoriasis is more common in the northern regions than in the southern regions of Canada [2] . In this study, the prevalence varied between the six provinces, but no difference was found between northern and southern China. Although psoriasis is generally not life-threatening, it has a number of negative impacts on quality of life, even in patients in whom the affected body surface area is relatively limited [19] . Studies have revealed that the impact on quality of life is related to the severity of the disease. In this study, nearly 60% of patients complained that their lives were negatively influenced by psoriasis. Interestingly, although most of patients had tried different treatments, there was a small percentage of patients who had never sought medical treatment.
